{"schema_version":"secwatch.filing_event.v1","accession":"0001935979-24-000002","form_type":"8-K","ticker":"BHVN","cik":"0001935979","company_name":"Biohaven Ltd.","filed_at":"2024-01-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.336964+00:00","generated_at":"2026-06-07T02:38:15.709749+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"low","headline":"Biohaven presents at J.P. Morgan Healthcare Conference; pipeline updates expected","bullets":["CEO Vlad Coric presented at the 42nd Annual J.P. Morgan Healthcare Conference on January 8, 2024.","Presentation likely covers clinical trial progress for OCD and other pipeline programs.","No specific financial or clinical data disclosed in the exhibit text provided.","Form 8-K furnishes the presentation as Exhibit 99.1 under Regulation FD."],"urls":{"canonical":"https://secwatch.observer/filing/0001935979-24-000002","json":"https://secwatch.observer/filing/0001935979-24-000002.json","markdown":"https://secwatch.observer/filing/0001935979-24-000002.md","text":"https://secwatch.observer/filing/0001935979-24-000002.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1935979/000193597924000002/0001935979-24-000002-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1935979/000193597924000002/bhvn-20240108.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T02:38:15.709749+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}